PCSK9 Inhibitor Research Paper

PCSK9 Inhibitor Research Paper

Research

2023 Family Heart Foundation Research Highlights

No Comments

When it comes to the diagnosis and treatment of familial hypercholesterolemia (FH) and elevated lipoprotein(a), or Lp(a), there are still so many unanswered questions.
What we have learned from our research is impacting peoples’ lives right now. We are using artificial intelligence to address the … Read More →


Shining a Light on LDL Cholesterol Management in America

No Comments

September is National Cholesterol Education Month, and that makes it the perfect time to shine a light on cholesterol management in America. Family Heart Foundation research shows that 70% of Americans at high-risk for cardiovascular disease never get their LDL (“bad”) cholesterol to recommended … Read More →


The US is Frequently Missing the HoFH Diagnosis

HoFH in the U.S.

Some High-Risk American Have Higher Rate of Cardiovascular Events

High-Risk American Not Reaching LDL-C Target Have Higher Rate of Cardiovascular Events

No Comments

Family Heart Foundation Research Finds High-Risk Americans Who Do Not Maintain Guideline Recommended LDL-C Targets Have 44% Higher Rate of Cardiovascular Events

Findings Based on Real-World Analysis to be Presented at AMCP 2023

SAN ANTONIO, March 21, 2023 – A real-world, retrospective analysis … Read More →


Lipoprotein(a) Risk Factors

Managing LDL Cholesterol

ACC 2023 Highlights